Glucosylceramide Beta-Glucosidase Deficiency Disease
4 clinical trials · Condition
◉ Watch Glucosylceramide Beta-Glucosidase Deficiency Disease
| Record | Firm | Date |
|---|---|---|
| A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients (NCT00358150) | Genzyme, a Sanofi Company | 2006-06-01 |
| Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease (NCT00364858) | Genzyme, a Sanofi Company | 2001-12-01 |
| A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. (NCT00365131) | Genzyme, a Sanofi Company | 1997-12-01 |
| International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry (NCT00358943) | Genzyme, a Sanofi Company | 1991-04-01 |
Track Glucosylceramide Beta-Glucosidase Deficiency Disease automatically
Every clearance here is in the API, with alerts when new ones post.